Entos is a series b startup based in United States. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Entos is a biotechnology company developing new therapeutics using its OrbNet platform, a structure-based drug design platform powered by machine learning. The company focuses on small molecule drug discovery.
Stage
series-b
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky